2023 clinical immunization safety assessment (cisa) base IDIQ

Active Awarded Last action

Contract number
75D30123F00001
Awardee
Awarding agency
Obligated
$855,741

Award facts

Opportunity
  • 75D30123R72866 Solicitation number
Contract value 78% obligated
  • $861,867.00 Current, with exercised options
  • $1,091,528.00 Potential, with all options
Completion date 61% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 10 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Roxbury, MA 02118, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00005 · Cisa clinical vaccine safety evaluation - contributing EO 14398 $219,354
Other Administrative Action P00004 · EO 14398 $0
Exercise an Option P00003 $218,269
Exercise an Option P00002 $217,216
Supplemental Agreement for work within scope P00001 $2,128
Original award $198,774

About this award

The CDC issued a delivery order to Boston Medical Center Corporation on September 28, 2023, with a ceiling value of $1,091,528, under the Clinical Immunization Safety Assessment (CISA) 2023–2028 IDIQ for clinical vaccine safety evaluation services contributing to Executive Order 14398.

CISA is a CDC-administered indefinite delivery contract supporting clinical immunization safety assessments through September 2028. Place of performance is Roxbury, MA. The delivery order carries a cost-no-fee pricing structure and ultimate completion date of September 27, 2028.

Under Service Contract Inventory reporting, this order invoiced $174 thousand in FY2024 across 0.4 FTEs and 882 contractor hours, at a derived government-paid rate of $197.38 per hour. FY2025 invoicing totaled $157 thousand across 0.4 FTEs. Boston Medical Center Corporation self-performed all reported labor with no subcontractors on this vehicle.

Quick answers

Who was awarded contract 75D30123F00001?

75D30123F00001 was awarded to Boston Medical Center Corporation by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 28, 2023.

How much is contract 75D30123F00001 worth?

The government has obligated $855,741 on 75D30123F00001. Its current value, with exercised options, is $861,867. Its potential value, with all options, is $1,091,528.

Is contract 75D30123F00001 an order under another contract?

Yes. 75D30123F00001 is a delivery order under 75D30123D17920, an indefinite delivery contract, on Clinical Immunization Safety Assessment 2023 - 2028 (CISA).

Was contract 75D30123F00001 competed?

The extent of competition for 75D30123F00001 was full and open competition. The government received 10 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award